HomeCompareZGSI vs MRK

ZGSI vs MRK: Dividend Comparison 2026

ZGSI yields 222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZGSI wins by $222.55M in total portfolio value
10 years
ZGSI
ZGSI
● Live price
222.22%
Share price
$0.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$222.60M
Annual income
$118,077,466.82
Full ZGSI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ZGSI vs MRK

📍 ZGSI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZGSIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZGSI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZGSI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZGSI
Annual income on $10K today (after 15% tax)
$18,888.89/yr
After 10yr DRIP, annual income (after tax)
$100,365,846.80/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ZGSI beats the other by $100,357,518.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZGSI + MRK for your $10,000?

ZGSI: 50%MRK: 50%
100% MRK50/50100% ZGSI
Portfolio after 10yr
$111.33M
Annual income
$59,043,632.48/yr
Blended yield
53.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ZGSI
No analyst data
Altman Z
-53.1
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZGSI buys
0
MRK buys
0
No recent congressional trades found for ZGSI or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZGSIMRK
Forward yield222.22%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$222.60M$56.8K
Annual income after 10y$118,077,466.82$9,798.13
Total dividends collected$210.95M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ZGSI vs MRK ($10,000, DRIP)

YearZGSI PortfolioZGSI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$32,922$22,222.22$11,206$366.19+$21.7KZGSI
2$103,601$68,374.29$12,650$502.35+$91.0KZGSI
3$311,940$201,087.08$14,407$694.19+$297.5KZGSI
4$899,634$565,858.11$16,585$967.82+$883.0KZGSI
5$2,487,779$1,525,170.19$19,342$1,363.89+$2.47MZGSI
6$6,603,594$3,941,670.79$22,913$1,947.19+$6.58MZGSI
7$16,844,187$9,778,341.19$27,662$2,823.89+$16.82MZGSI
8$41,333,753$23,310,473.31$34,159$4,173.35+$41.30MZGSI
9$97,686,273$53,459,157.08$43,337$6,308.80+$97.64MZGSI
10$222,601,779$118,077,466.82$56,776$9,798.13+$222.55MZGSI

ZGSI vs MRK: Complete Analysis 2026

ZGSIStock

Zero Gravity Solutions, Inc., an agricultural biotechnology company, focuses on the commercialization of technology derived from and designed for long term spaceflight and planetary colonization with applications to agriculture on earth. The company offers BAM-FX, an ionic nutrient delivery platform for food crops that deliver minerals and micronutrients systemically at the cellular level of a plant; and Directed Selection, which relates to the production and alteration of various novel stem cells with characteristics in the prolonged zero/micro gravity environment of the International Space Station. It patents its stem cells for commercial sale to third parties. The company was formerly known as ElectroHealing Technologies, Inc. and changed its name to Zero Gravity Solutions, Inc. in January 2013. Zero Gravity Solutions, Inc. was founded in 1983 and is headquartered in Boca Raton, Florida.

Full ZGSI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ZGSI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZGSI vs SCHDZGSI vs JEPIZGSI vs OZGSI vs KOZGSI vs MAINZGSI vs JNJZGSI vs ABBVZGSI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.